Telomere, DNA damage, and oxidative stress in stem cell aging

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 90, Issue 4, 2010, Pages 297-307

  Zhang, Junling ^a,b   Ju, Zhenyu ^a  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^b INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Aging; ROS; Stem cell; Telomere

Indexed keywords

CD150 ANTIGEN; CD34 ANTIBODY; FLT3 LIGAND; NUCLEOPROTEIN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FKHR;

BONE MARROW; CELL AGING; CELL FUNCTION; CELL TRANSPLANTATION; DNA DAMAGE; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; INTESTINE; KNOCKOUT MOUSE; MYELOPROLIFERATIVE DISORDER; NEURAL STEM CELL; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY MECHANISM; REVIEW; TELOMERE; TISSUE REGENERATION;

APOPTOSIS; CELL AGING; DNA DAMAGE; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; STEM CELLS; TELOMERE;

EID: 78650459376     PISSN: 1542975X     EISSN: 15429768     Source Type: Journal    
DOI: 10.1002/bdrc.20190     Document Type: Review

References (132)

1. Allen ND, Baird DM. 2009. Telomere length maintenance in stem cell populations. Biochim Biophys Acta 1792: 324- 328.
2. Allsopp RC, Morin GB, DePinho R, et al. 2003a. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102: 517-520.
3. Allsopp RC, Morin GB, Horner JW, et al. 2003b. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat Med 9: 369-371.
4. Atzmon G, Cho M, Cawthon RM, et al. 2010. Evolution in health and medicine Sackler colloquium: genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc Natl Acad Sci USA 107 (Suppl 1): 1710-1717.
5. Baum CM, Weissman IL, Tsukamoto AS, et al. 1992. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89: 2804-2808.
6. Beerman I, Bhattacharya D, Zandi S, et al. 2010. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci USA 107: 5465-5470.
7. Begus-Nahrmann Y, Lechel A, Obenauf AC, et al. 2009. p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat Genet 41: 1138-1143.
8. Bertoncello I, Hodgson GS, Bradley TR. 1985. Multiparameter analysis of transplantable hemopoietic stem cells. I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. Exp Hematol 13: 999-1006.
9. Blackburn EH. 2001. Switching and signaling at the telomere. Cell 106: 661-673.
10. Blasco MA, Lee HW, Hande MP, et al. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
11. Brack AS, Murphy-Seiler F, Hanifi J, et al. 2009. BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration. Dev Biol 335: 93-105.
12. Brown JP, Wei W, Sedivy JM. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277: 831-834.
13. Chen Q, Fischer A, Reagan JD, et al. 1995. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 92: 4337-4341.
14. Cheng T, Rodrigues N, Shen H, et al. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287: 1804-1808.
15. Chin L, Artandi SE, Shen Q, et al. 1999. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97: 527-538.
16. Cho RH, Sieburg HB, Muller-Sieburg CE. 2008. A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 111: 5553-5561.
17. Choudhury AR, Ju Z, Djojosubroto MW, et al. 2007. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 39: 99-105.
18. Cimprich KA. 2007. Probing ATR activation with model DNA templates. Cell Cycle 6: 2348-2354.
19. Collado M, Blasco MA, Serrano M. 2007. Cellular senescence in cancer and aging. Cell 130: 223-233.
20. Conboy IM, Conboy MJ, Wagers AJ, et al. 2005. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764.
21. Cross SM, Sanchez CA, Morgan CA, et al. 1995. A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356.
22. de Lange T. 2005. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100-2110.
23. Deng C, Zhang P, Harper JW, et al. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
24. Djojosubroto MW, Choi YS, Lee HW, Rudolph KL. 2003. Telomeres and telomerase in aging, regeneration and cancer. Mol Cells 15: 164-175.
25. Donehower LA, Harvey M, Slagle BL, et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
26. Ema H, Morita Y, Yamazaki S, et al. 2006. Adult mouse hematopoietic stem cells: purification and single-cell assays. Nat Protoc 1: 2979-2987.
27. Enwere E, Shingo T, Gregg C, et al. 2004. Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination. J Neurosci 24: 8354-8365.
28. Essers MA, Offner S, Blanco-Bose WE, et al. 2009. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458: 904-908.
29. Fabrizio P, Liou LL, Moy VN, et al. 2003. SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics 163: 35-46.
30. Fabrizio P, Pletcher SD, Minois N, et al. 2004. Chronological aging-independent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett 557: 136-142.
31. Ferron SR, Marques-Torrejon MA, Mira H, et al. 2009. Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis. J Neurosci 29: 14394-14407.
32. Finkel T, Serrano M, Blasco MA. 2007. The common biology of cancer and ageing. Nature 448: 767-774.
33. Flores I, Blasco MA. 2010. The role of telomeres and telomerase in stem cell aging. FEBS Lett 584: 3826-3830.
34. Flores I, Cayuela ML, Blasco MA. 2005. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309: 1253-1256.
35. Flores I, Canela A, Vera E, et al. 2008. The longest telomeres: a general signature of adult stem cell compartments. Genes Dev 22: 654-667.
36. Fraga CG, Shigenaga MK, Park JW, et al. 1990. Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 87: 4533-4537.
37. Friedman JS, Rebel VI, Derby R, et al. 2001. Absence of mitochondrial superoxide dismutase results in a murine hemolytic anemia responsive to therapy with a catalytic antioxidant. J Exp Med 193: 925-934.
38. Friedman JS, Lopez MF, Fleming MD, et al. 2004. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood 104: 2565-2573.
39. Fukasawa K, Choi T, Kuriyama R, et al. 1996. Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747.
40. Giangreco A, Qin M, Pintar JE, Watt FM. 2008. Epidermal stem cells are retained in vivo throughout skin aging. Aging Cell 7: 250-259.
41. Giorgio M, Migliaccio E, Orsini F, et al. 2005. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233.
42. Goodell MA, Brose K, Paradis G, et al. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806.
43. Goodell MA, Rosenzweig M, Kim H, et al. 1997. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3: 1337-1345.
44. Greer EL, Brunet A. 2005. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-7425.
45. Greider CW, Blackburn EH. 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43 (2, Part 1): 405-413.
46. Guachalla LM, Ju Z, Koziel R, et al. 2009. Sod2 haploinsufficiency does not accelerate aging of telomere dysfunctional mice. Aging (Albany, NY) 1: 303-315.
47. Hamilton ML, Van Remmen H, Drake JA, et al. 2001. Does oxidative damage to DNA increase with age? Proc Natl Acad Sci USA 98: 10469-10474.
48. Harman D. 1956. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298-300.
49. Hattiangady B, Shetty AK. 2008. Aging does not alter the number or phenotype of putative stem/progenitor cells in the neurogenic region of the hippocampus. Neurobiol Aging 29: 129-147.
50. Hayflick L. 1998. How and why we age. Exp Gerontol 33: 639-653.
51. Itahana K, Zou Y, Itahana Y, et al. 2003. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 23: 389-401.
52. Ito K, Hirao A, Arai F, et al. 2004. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431: 997-1002.
53. Ito K, Hirao A, Arai F, et al. 2006. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12: 446-451.
54. Jacks T, Remington L, Williams BO, et al. 1994. Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7.
55. Jang YY, Sharkis SJ. 2007. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 110: 3056-3063.
56. Janzen V, Forkert R, Fleming HE, et al. 2006. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443: 421-426.
57. Jeffers JR, Parganas E, Lee Y, et al. 2003. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4: 321-328.
58. Kakoki M, Kizer CM, Yi X, et al. 2006. Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors. J Clin Invest 116: 1302-1309.
59. Kemp CJ, Wheldon T, Balmain A. 1994. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 8: 66-69.
60. Kiel MJ, Yilmaz OH, Iwashita T, et al. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109-1121.
61. Kim M, Cooper DD, Hayes SF, Spangrude GJ. 1998. Rhodamine-123 staining in hematopoietic stem cells of young mice indicates mitochondrial activation rather than dye efflux. Blood 91: 4106-4117.
62. Kippin TE, Martens DJ, van der Kooy D. 2005. p21 loss compromises the relative quiescence of forebrain stem cell proliferation leading to exhaustion of their proliferation capacity. Genes Dev 19: 756-767.
63. Kirstetter P, Anderson K, Porse BT, et al. 2006. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol 7: 1048-1056.
64. Kollman C, Howe CW, Anasetti C, et al. 2001. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98: 2043-2051.
65. Kops GJ, Dansen TB, Polderman PE, et al. 2002. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321.
66. Krishnamurthy J, Ramsey MR, Ligon KL, et al. 2006. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443: 453-457.
67. Lee JM, Abrahamson JL, Kandel R, et al. 1994. Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice. Oncogene 9: 3731-3736.
68. Lee HW, Blasco MA, Gottlieb GJ, et al. 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574.
69. Lessard J, Sauvageau G. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255-260.
70. Leung C, Lingbeek M, Shakhova O, et al. 2004. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428: 337-341.
71. Lieber MR, Karanjawala ZE. 2004. Ageing, repetitive genomes and DNA damage. Nat Rev Mol Cell Biol 5: 69-75.
72. Lin MT, Beal MF. 2006. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795.
73. Linton PJ, Dorshkind K. 2004. Age-related changes in lymphocyte development and function. Nat Immunol 5: 133-139.
74. Liu D, O'Connor MS, Qin J, Songyang Z. 2004. Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem 279: 51338-51342.
75. Liu H, Fergusson MM, Castilho RM, et al. 2007. Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317: 803-806.
76. Liu J, Cao L, Chen J, et al. 2009. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459: 387-392.
77. Maringele L, Lydall D. 2002. EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70Delta mutants. Genes Dev 16: 1919-1933.
78. Martinez P, Thanasoula M, Munoz P, et al. 2009. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev 23: 2060-2075.
79. Maslov AY, Barone TA, Plunkett RJ, Pruitt SC. 2004. Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice. J Neurosci 24: 1726-1733.
80. Michalak EM, Villunger A, Adams JM, Strasser A. 2008. In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15: 1019-1029.
81. Miyamoto K, Araki KY, Naka K, et al. 2007. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 1: 101-112.
82. Molofsky AV, Pardal R, Iwashita T, et al. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425: 962-967.
83. Molofsky AV, Slutsky SG, Joseph NM, et al. 2006. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443: 448-452.
84. Morita Y, Ema H, Nakauchi H. 2010. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 207: 1173-1182.
85. Morrison SJ, Weissman IL. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1: 661-673.
86. Muller-Sieburg C, Sieburg HB. 2008. Stem cell aging: survival of the laziest? Cell Cycle 7: 3798-3804.
87. Nalapareddy K, Jiang H, Guachalla Gutierrez LM, Rudolph KL. 2008. Determining the influence of telomere dysfunction and DNA damage on stem and progenitor cell aging: what markers can we use? Exp Gerontol 43: 998-1004.
88. Nijnik A, Woodbine L, Marchetti C, et al. 2007. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447: 686-690.
89. Njajou OT, Hsueh WC, Blackburn EH, et al. 2009. Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci 64: 860-864.
90. Oliver CN, Ahn BW, Moerman EJ, et al. 1987. Age-related changes in oxidized proteins. J Biol Chem 262: 5488- 5491.
91. Osawa M, Hanada K, Hamada H, Nakauchi H. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273: 242-245.
92. Paik JH, Ding Z, Narurkar R, et al. 2009. FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell 5: 540-553.
93. Passos JF, Saretzki G, Ahmed S, et al. 2007. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 5: e110.
94. Piccin D, Morshead CM. 2010. Potential and pitfalls of stem cell therapy in old age. Dis Model Mech 3: 421-425.
95. Ristow M, Zarse K, Oberbach A, et al. 2009. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 106: 8665-8670.
96. Rossi DJ, Bryder D, Seita J, et al. 2007. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447: 725-729.
97. Rossi DJ, Jamieson CH, Weissman IL. 2008. Stems cells and the pathways to aging and cancer. Cell 132: 681-696.
98. Rudolph KL, Chang S, Lee HW, et al. 1999. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701-712.
99. Ruzankina Y, Pinzon-Guzman C, Asare A, et al. 2007. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 1: 113-126.
100. Ruzankina Y, Schoppy DW, Asare A, et al. 2009. Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53. Nat Genet 41: 1144-1149.
101. Samper E, Fernandez P, Eguia R, et al. 2002. Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood 99: 2767-2775.
102. Sangiorgi E, Capecchi MR. 2008. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 40: 915-920.
103. Satyanarayana A, Greenberg RA, Schaetzlein S, et al. 2004. Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling. Mol Cell Biol 24: 5459-5474.
104. Schaetzlein S, Kodandaramireddy NR, Ju Z, et al. 2007. Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice. Cell 130: 863-877.
105. Scheller M, Huelsken J, Rosenbauer F, et al. 2006. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat Immunol 7: 1037-1047.
106. Schriner SE, Linford NJ, Martin GM, et al. 2005. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308: 1909-1911.
107. Schulz TJ, Zarse K, Voigt A, et al. 2007. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab 6: 280-293.
108. Shampay J, Szostak JW, Blackburn EH. 1984. DNA sequences of telomeres maintained in yeast. Nature 310: 154-157.
109. Sharpless NE, DePinho RA. 2007. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8: 703-713.
110. Sitte N, Merker K, von Zglinicki T, Grune T. 2000. Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. Free Radic Biol Med 28: 701-708.
111. Sohal RS, Weindruch R. 1996. Oxidative stress, caloric restriction, and aging. Science 273: 59-63.
112. Spangrude GJ, Johnson GR. 1990. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci USA 87: 7433-7437.
113. Spangrude GJ, Heimfeld S, Weissman IL. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
114. Szostak JW, Blackburn EH. 1982. Cloning yeast telomeres on linear plasmid vectors. Cell 29: 245-255.
115. Takubo K, Goda N, Yamada W, et al. 2010. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7: 391-402.
116. Tothova Z, Kollipara R, Huntly BJ, et al. 2007. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128: 325-339.
117. Unterluggauer H, Hampel B, Zwerschke W, Jansen-Durr P. 2003. Senescence-associated cell death of human endothelial cells: the role of oxidative stress. Exp Gerontol 38: 1149-1160.
118. van der Lugt NM, Domen J, Linders K, et al. 1994. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 8: 757-769.
119. van Os R, Kamminga LM, Ausema A, et al. 2007. A Limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning. Stem Cells 25: 836-843.
120. Van Remmen H, Ikeno Y, Hamilton M, et al. 2003. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 16: 29-37.
121. Villunger A, Michalak EM, Coultas L, et al. 2003. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038.
122. Vina J, Borras C, Miquel J. 2007. Theories of ageing. IUBMB Life 59: 249-254.
123. Vulliamy T, Dokal I. 2006. Dyskeratosis congenita. Semin Hematol 43: 157-166.
124. Weissman IL. 2000. Stem cells: units of development, units of regeneration, and units in evolution. Cell 100: 157-168.
125. Wilson A, Laurenti E, Oser G, et al. 2008. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135: 1118-1129.
126. Yamazaki S, Iwama A, Takayanagi S, et al. 2006. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 25: 3515-3523.
127. Yamazaki S, Iwama A, Takayanagi S, et al. 2009. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood 113: 1250-1256.
128. Yilmaz OH, Valdez R, Theisen BK, et al. 2006. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: 475-482.
129. Yu H, Yuan Y, Shen H, Cheng T. 2006. Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners. Blood 107: 1200-1206.
130. Yuan Y, Shen H, Franklin DS, et al. 2004. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol 6: 436-442.
131. Zhang J, Grindley JC, Yin T, et al. 2006. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441: 518-522.
132. Zhao C, Deng W, Gage FH. 2008. Mechanisms and functional implications of adult neurogenesis. Cell 132: 645-660.